Please enable Javascript
Lorenza Rimassa, MD
Lorenza Rimassa, MD
Articles by Lorenza Rimassa, MD
The HIMALAYA Study: STRIDE for uHCC Shows Beneficial 5-Year OS Results
Lorenza Rimassa, MD
Conference Coverage
|
October 4, 2024
HIMALAYA found tremelimumab plus durvalumab to significantly improve overall survival over sorafenib alone.
View More